1-9 of 9
Amy J. Davidoff, M.S., Ph.D.
Close
Sort by
Journal Articles

Short Survival and High Rates of Transformation Prevail in Chronic Myelomonocytic Leukemia Despite Hypomethylating Agent Therapy.

Emily J. Vannorsdall, M.D., Vu H. Duong, M.D., Xinyi Ng, B.S., Dan P. Zandberg, M.D., Michael L. Tidwell, C.R.N.P., Amy J. Davidoff, M.S., Ph.D., Maria R. Baer, M.D.
Journal: Blood
Blood (2012) 120 (21): 2800.
https://doi.org/10.1182/blood.V120.21.2800.2800
Published: 2012
Journal Articles

Medicare Prescription Drug Coverage and Home Use of Erythropoiesis-Stimulating Agents for MDS-Associated Anemia: A Medicare-Database Analysis.

Amy J. Davidoff, M.S., Ph.D., Franklin Hendrick, B.S., Bruce C. Stuart, PhD, Amer M. Zeidan, MD, Rahul Shenolikar, PhD, Steven D. Gore, MD, Maria R. Baer, M.D.
Journal: Blood
Blood (2012) 120 (21): 3176.
https://doi.org/10.1182/blood.V120.21.3176.3176
Published: 2012
Journal Articles

Utilization Patterns of Iron Chelation Therapy in Transfusion-Dependent Myelodysplastic Syndrome Patients Enrolled in Medicare Part D.

Amer M. Zeidan, MD, Maria R. Baer, M.D., Steven D. Gore, MD, Medha Sasane, BPharm, PhD, Carole Paley, MD, Diane L. McNally, BSPharm, M.S., Amy J. Davidoff, M.S., Ph.D.
Journal: Blood
Blood (2012) 120 (21): 3178.
https://doi.org/10.1182/blood.V120.21.3178.3178
Published: 2012
Journal Articles

Association Between FDA Safety Warnings, CMS Coverage Restrictions and Adherence to Guidelines for ESA Use in Patients with Myelodysplastic Syndromes

Franklin Hendrick, B.S., Amy J. Davidoff, M.S., Ph.D., Amer M. Zeidan, MD, Steven D. Gore, MD, Maria R. Baer, M.D.
Journal: Blood
Blood (2012) 120 (21): 971.
https://doi.org/10.1182/blood.V120.21.971.971
Published: 2012
Journal Articles

Lenalidomide Performance in the Real World: Patterns of Utilization and Effectiveness in a Medicare Population with Myelodysplastic Syndromes

Amer M. Zeidan, MD, Steven D. Gore, MD, Diane L. McNally, BSPharm, M.S., Maria R. Baer, M.D., Franklin Hendrick, B.S., Dalia Mahmoud, MBA, Amy J. Davidoff, M.S., Ph.D.
Journal: Blood
Blood (2012) 120 (21): 3837.
https://doi.org/10.1182/blood.V120.21.3837.3837
Published: 2012
Journal Articles

Deferasirox Is Associated with Reduced Mortality Risk in a Medicare Population with Myelodysplastic Syndromes

Amer M. Zeidan, MD, Franklin Hendrick, B.S., Erika Friedmann, PhD, Steven D. Gore, MD, Maria R. Baer, M.D., Medha Sasane, BPharm, PhD, Carole Paley, MD, Diane L. McNally, BSPharm, M.S., Amy J. Davidoff, M.S., Ph.D.
Journal: Blood
Blood (2012) 120 (21): 426.
https://doi.org/10.1182/blood.V120.21.426.426
Published: 2012
Journal Articles

Chronic Myelomonocytic Leukemia Is Associated with More Frequent and More Rapid Progression to Acute Myeloid Leukemia and Shorter Survival Than Myelodysplastic Syndrome, but Is Less Frequently Treated: Analysis of Surveillance Epidemiology and End Results Data Linked to Medicare Enrollment Claims

Dan Zandberg, MD, Ting-Ying Huang, BSPharm, Xuehua Ke, M.A., Maria R. Baer, MD, Steven D. Gore, MD, Sheila Weiss Smith, PhD, FISPE, Amy J. Davidoff, M.S., Ph.D.
Journal: Blood
Blood (2011) 118 (21): 2784.
https://doi.org/10.1182/blood.V118.21.2784.2784
Published: 2011
Journal Articles

Do Erythropoiesis-Stimulating Agents (ESAs) Affect Survival in Anemic Patients with Myelodysplastic Syndromes (MDS)?

Amy J. Davidoff, M.S., Ph.D., Xuehua Ke, M.A., Maria R. Baer, MD, Sheila R Weiss Smith, PhD, Dan Zandberg, MD, Franklin Hendrick, B.S., Masayo Sato, M.S., Peter L. Greenberg, MD, Steven D. Gore, MD
Journal: Blood
Blood (2011) 118 (21): 2794.
https://doi.org/10.1182/blood.V118.21.2794.2794
Published: 2011
Journal Articles

Tertiary Center Referral Patterns for Myelodysplastic Syndrome (MDS) Patients Are Suggestive of Age and Race Disparities

Dan P. Zandberg, M.D., Jason Bierenbaum, M.D., Ivana Gojo, M.D., Michael L. Tidwell, C.R.N.P., Yi Ning, Ph.D., Xianfeng Frank Zhao, M.D., Ph.D., Amy J. Davidoff, M.S., Ph.D., Maria R. Baer, M.D.
Journal: Blood
Blood (2010) 116 (21): 1881.
https://doi.org/10.1182/blood.V116.21.1881.1881
Published: 2010